BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1289616)

  • 1. Recombinant human epidermal growth factor and corneal neovascularization.
    Nezu E; Ohashi Y; Kinoshita S; Manabe R
    Jpn J Ophthalmol; 1992; 36(4):401-6. PubMed ID: 1289616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of recombinant epidermal growth factor in corneal angiogenesis].
    Taniguchi E; Nagae Y; Watanabe H; Ohashi Y; Kinoshita S; Manabe R
    Nippon Ganka Gakkai Zasshi; 1991 Jan; 95(1):52-8. PubMed ID: 1710416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor.
    Knighton DR; Phillips GD; Fiegel VD
    J Trauma; 1990 Dec; 30(12 Suppl):S134-44. PubMed ID: 1701493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release endotoxin. A model for inducing corneal neovascularization.
    Li WW; Grayson G; Folkman J; D'Amore PA
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2906-11. PubMed ID: 1917394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of rabbit corneal alkali wounds with human epidermal growth factor.
    Chung JH; Fagerholm P
    Cornea; 1989; 8(2):122-8. PubMed ID: 2469551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug modification of angiogenesis in a rat cornea model.
    Schwartz S; George J; Ben-Shoshan J; Luboshits G; Avni I; Levkovitch-Verbin H; Ziv H; Rosner M; Barak A
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):250-4. PubMed ID: 18172099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of angiogenesis in the mouse cornea.
    Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide.
    BenEzra D; Griffin BW; Maftzir G; Aharonov O
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3601-8. PubMed ID: 8258518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
    Shan S; Lockhart AC; Saito WY; Knapp AM; Laderoute KR; Dewhirst MW
    Clin Cancer Res; 2001 Aug; 7(8):2590-6. PubMed ID: 11489843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel.
    Yang CF; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Tabata Y; Ikada Y; Ogura Y
    Ophthalmic Res; 2000; 32(1):19-24. PubMed ID: 10657751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis effects of nerve growth factor (NGF) on rat corneas.
    Seo K; Choi J; Park M; Rhee C
    J Vet Sci; 2001 Aug; 2(2):125-30. PubMed ID: 14614283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor.
    Loughman MS; Chatzistefanou K; Gonzalez EM; Flynn E; Adamis AP; Shing Y; D'Amato RJ; Folkman J
    Aust N Z J Ophthalmol; 1996 Aug; 24(3):289-95. PubMed ID: 8913136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of experimental angiogenesis of cornea by somatostatin.
    Wu PC; Liu CC; Chen CH; Kou HK; Shen SC; Lu CY; Chou WY; Sung MT; Yang LC
    Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):63-9. PubMed ID: 12545294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of angiogenesis due to basic fibroblast growth factor in a modified rabbit corneal model.
    Gaudric A; N'guyen T; Moenner M; Glacet-Bernard A; Barritault D
    Ophthalmic Res; 1992; 24(3):181-8. PubMed ID: 1407961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant epidermal growth factor in experimental corneal wound healing.
    Brazzell RK; Stern ME; Aquavella JV; Beuerman RW; Baird L
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):336-40. PubMed ID: 1993585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of accelerated corneal epithelial healing by human epidermal growth factor.
    Kitazawa T; Kinoshita S; Fujita K; Araki K; Watanabe H; Ohashi Y; Manabe R
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1773-8. PubMed ID: 2211024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea.
    Tamada Y; Fukiage C; Boyle DL; Azuma M; Shearer TR
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):271-83. PubMed ID: 10872924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of transforming growth factor-beta 1 in the control of corneal neovascularization.
    Friling R; Yassur Y; Levy R; Kost J; Schwartz B; Mikhailowsky R; Lamprecht SA
    In Vivo; 1996; 10(1):59-64. PubMed ID: 8726812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.